Neonatal infectious diseases: evaluation of neonatal sepsis.

Abstract

Neonatal sepsis remains a feared cause of morbidity and mortality in the neonatal period. Maternal, neonatal, and environmental factors are associated with risk of infection, and a combination of prevention strategies, judicious neonatal evaluation, and early initiation of therapy are required to prevent adverse outcomes. This article reviews recent trends in epidemiology and provides an update on risk factors, diagnostic methods, and management of neonatal sepsis.

• Authors: Andres Camacho-Gonzalez, Paul W Spearman, Barbara J Stoll
• Journal: Pediatric clinics of North America (Pediatr Clin North Am) Vol. 60 Issue 2 Pg. 367-89 (Apr 2013) ISSN: 1557-8240 [Electronic] United States
• PMID: 23481106 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2013 Elsevier Inc. All rights reserved.

Chemical References

• Anti-Infective Agents
• Antibodies, Monoclonal
• Antifungal Agents
• Biomarkers
• Immunoglobulins, Intravenous
• Fluconazole
• C-Reactive Protein
• Lactoferrin

Topics

• Adaptive Immunity
• Anti-Infective Agents (administration & dosage)
• Antibodies, Monoclonal (administration & dosage)
• Antifungal Agents (administration & dosage)
• Bacterial Infections (complications)
• Biomarkers (blood)
• Blood Cell Count
• C-Reactive Protein (metabolism)
• Candidiasis (complications)
• Escherichia coli Infections (complications, immunology)
• Fluconazole (administration & dosage)
• Genomics
• Humans
• Immunity, Innate
• Immunoglobulins, Intravenous (administration & dosage)
• Infant, Newborn
• Infant, Newborn, Diseases (blood, drug therapy, epidemiology, immunology, microbiology)
• Lactoferrin (administration & dosage)
• Polymerase Chain Reaction
• Predictive Value of Tests
• Proteomics
• Risk Factors
• Sepsis (blood, drug therapy, epidemiology, immunology, microbiology, prevention & control)
• Streptococcal Infections (complications, immunology)
• Streptococcus agalactiae (immunology, isolation & purification)